Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
The results demonstrated that vitamin D supplementation significantly reduced triglyceride levels (MD = −12.64, 95% CI [−21.23∼−4.04], P = 0.004).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Review / evidence synthesis.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Effect of vitamin D supplementation on blood lipids in patients with metabolic syndrome: a meta-analysis
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Effect of vitamin D supplementation on blood lipids in patients with metabolic syndrome: a meta-analysis
Review / evidence synthesis · PeerJ · 2026
Original publication title
Effect of vitamin D supplementation on blood lipids in patients with metabolic syndrome: a meta-analysis
©2026 Wang et al.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
This meta-analysis evaluated the effects of vitamin D supplementation on blood lipids in patients with metabolic syndrome.
Source: ObjectivesAbstract: What methods does the paper describe?
We searched the randomized controlled trials from 1948 to February 1, 2026 involving vitamin D supplementation treatment for patients with metabolic syndrome from PubMed, EMBASE, Cochrane library, SinoMed, and conducted a meta-analysis. The meta-analysis was registered on the PROSPERO, the registration number is CRD42024591657.
Source: MethodsAbstract: Results
Finally, seven trials were included in the meta-analysis. The results demonstrated that vitamin D supplementation significantly reduced triglyceride levels (MD = −12.64, 95% CI [−21.23∼−4.04], P = 0.004). However, no significant differences were observed in total cholesterol or low-density lipoprotein cholesterol levels between the vitamin D treated groups and control groups. Notably, vitamin D supplementation showed potential benefits in increasing high-density lipoprotein cholesterol levels particularly with daily regimens (MD = 1.77, 95% CI [0.90∼2.64] P < 0.0001, I2 = 35%).
Source: ResultsAbstract: Conclusions
Our meta-analysis confirmed the effects of vitamin D in the management of triglyceride level in metabolic syndrome patients. Vitamin D supplementation showed potential benefits on increasing the high-density lipoprotein cholesterol levels especially with daily regimens. More randomized controlled trials are needed to confirm the result.
Source: ConclusionsAuthors’ abstract
Background
Vitamin D, a fat-soluble vitamin critical for bone metabolism, has recently been implicated in metabolic homeostasis. Growing evidence suggests its potential role in modulating lipid profiles in metabolic syndrome.
Objectives
This meta-analysis evaluated the effects of vitamin D supplementation on blood lipids in patients with metabolic syndrome.
Methods
We searched the randomized controlled trials from 1948 to February 1, 2026 involving vitamin D supplementation treatment for patients with metabolic syndrome from PubMed, EMBASE, Cochrane library, SinoMed, and conducted a meta-analysis. The meta-analysis was registered on the PROSPERO, the registration number is CRD42024591657.
Results
Finally, seven trials were included in the meta-analysis. The results demonstrated that vitamin D supplementation significantly reduced triglyceride levels (MD = −12.64, 95% CI [−21.23∼−4.04], P = 0.004). However, no significant differences were observed in total cholesterol or low-density lipoprotein cholesterol levels between the vitamin D treated groups and control groups. Notably, vitamin D supplementation showed potential benefits in increasing high-density lipoprotein cholesterol levels particularly with daily regimens (MD = 1.77, 95% CI [0.90∼2.64] P < 0.0001, I2 = 35%).
Conclusions
Our meta-analysis confirmed the effects of vitamin D in the management of triglyceride level in metabolic syndrome patients. Vitamin D supplementation showed potential benefits on increasing the high-density lipoprotein cholesterol levels especially with daily regimens. More randomized controlled trials are needed to confirm the result.
Publication and source details
Original title: Effect of vitamin D supplementation on blood lipids in patients with metabolic syndrome: a meta-analysis
Qijun Wang; Hong Huang; Wenshu Jin; Shaoguan Wang; Xiaofang Tu
PeerJ · 2026
©2026 Wang et al.2026Wang et al.https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.The authors received no funding for this work.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T16:26:51.282843+00:00
DOI: 10.7717/peerj.21086 · PMC13086024